Preparing for the inevitable: Government enforcement and qui tams looming for healthcare and life sciences companies

Please join us for a webinar focused on preparing healthcare and life sciences companies for the looming government enforcement and qui tam activity likely to result from the COVID-19 pandemic, including:

• Regulatory traps for the unwary: Understanding the current pandemic-related regulatory issues which will be the basis for future government enforcement and qui tam activity.
• Know the players: Which government institutions and personnel will be involved in enforcement activities and what their priorities relevant to healthcare and life sciences companies will be.
• Preparing the defense: What companies should be doing now to minimize risk and position for best possible outcomes. 

Speakers

• Samuel Ramer, Partner, Norton Rose Fulbright US LLP
• Keith Rosen, Head of Risk Advisory, United States, Norton Rose Fulbright US LLP
• Chandra Westergaard, Partner, Norton Rose Fulbright US LLP
• Jeff Wurzburg, Senior Counsel, Norton Rose Fulbright US LLP